New trigger method for egg retrieval in fertility treatment
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests a new way to trigger final egg maturation during in vitro fertilization (IVF) for people who respond normally to fertility medications. The goal is to see if this modified approach improves egg quality or success rates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are undergoing IVF using a GnRH antagonist protocol (a type of fertility medication that prevents premature ovulation)
- You respond normally to ovulation-stimulating medications (neither over- nor under-respond)
- You do not have hypogonadotropic hypogonadism (a rare hormone condition affecting testicular or ovarian function)
- You do not have endometriosis (a condition where tissue similar to the uterine lining grows outside the uterus)
- You do not have a history of recurrent miscarriages (three or more consecutive pregnancy losses)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.
This trial tests a medication called human menopausal gonadotropin to help women undergoing IVF achieve a live birth. It focuses on the cumulative success rate after freezing and later transferring embryos.
This trial compares two methods to trigger final egg maturation in people undergoing IVF who have had poor response to fertility medications in past cycles. The goal is to improve egg quality and increase chances of successful pregnancy.
This trial tests whether using multiple smaller doses of a trigger medication works better than one large dose for women who respond very strongly to fertility drugs during IVF. The goal is to improve egg quality and reduce side effects in women whose ovaries produce many eggs.
This trial tests if using two medications (hCG and GnRH agonist) together as a trigger improves success rates for frozen embryo transfers in natural menstrual cycles. It may help women who are preparing for this procedure.
Hear when a new Infertility (IVF Patients) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.